Clinically relevant safety issues associated with St. John's wort product labels

BMC Complementary and Alternative Medicine

Volumn 8, Issue , 2008, Pages

  Clauson, Kevin A ^a   Santamarina, Marile L ^b   Rutledge, Jennifer C ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b PALM BEACH ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HYPERICUM PERFORATUM EXTRACT; IMMUNOSUPPRESSIVE AGENT; ORAL CONTRACEPTIVE AGENT; WARFARIN; PLANT EXTRACT;

ARTICLE; BIPOLAR DISORDER; CONSULTATION; CONSUMER HEALTH INFORMATION; DRUG CONTRAINDICATION; DRUG INFORMATION; DRUG INTERACTION; DRUG LABELING; DRUG SAFETY; HEALTH CARE PERSONNEL; PHOTOTOXICITY; DIET SUPPLEMENTATION; FOOD AND DRUG ADMINISTRATION; HERB DRUG INTERACTION; HUMAN; HYPERICUM; METHODOLOGY; PACKAGING; SAFETY; STANDARD; UNITED STATES;

CONSUMER PRODUCT SAFETY; DIETARY SUPPLEMENTS; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PLANT EXTRACTS; PRODUCT LABELING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 48249156972     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-8-42     Document Type: Article

References (36)

1. Nutrition Business Journal http://www.nutritionbusiness.com (accessed February 17, 2008)
2. Natural Medicines Comprehensive Database http://www.naturaldatabase.com (accessed February 17, 2008).
3. Natural Standard http://www.naturalstandard.com (accessed February 17, 2008)
4. Charrois TL Hill RH Vu D Foster BC Boon HS Cramer K Vohra S Community identification of natural health product-drug interactions Ann Pharmacother 2007. 41:1124-9. 10.1345/aph.1H463 17578882
5. Ufer M Meyer SA Junge O Selke G Volz HP Hedderich J Gleiter CH Patterns and prevalence of antidepressant use in the German state of Baden-Wuerttemberg: A prescription-based analysis Pharmacoepidemiol Drug Saf 2007:1153-60. 10.1002/pds.1405 17443868
6. Pilkington K Boshnakova A Richardson J St. John's wort for depression: time for a different perspective? Complement Ther Med 2006, 14:268-81. 10.1016/j.ctim.2006.01.003 17105697
7. Kasper S Anghelescu IG Szegedi A Dienel A Kieser M Superior efficacy of St. John's wort extract WS 5570 compared to placebo in patients with major depression: A randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298] BMC Med 2006, 4:14. 1538611 16796730 10.1186/1741-7015-4-14
8. Papakostas GI Crawford CM Scalia MJ Fava M Timing of clinical improvement and symptom resolution in the treatment of major depression disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine Neuropsychobiology 2007, 56(2-3):132-7. 10.1159/000115779 18259086
9. Calapai G Cripu A Firenzuoli F Inferrera G Squadrito F Parisi A De Sarro G Caputi A Serotonin, norepinepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum Pharmacopsychiatry 2001, 34:45-9. 10.1055/s-2001-15180 11302563
10. Hammerness P Basch E Ulbricht C Barrette EP Foppa I Basch S Bent S Boon H Ernst E Natural Standard Research Collaboration St. John's wort: A systematic review of adverse effects and drug interactions for the consultation psychiatrist Psychosomatics 2003, 44:271-282. 10.1176/ appi.psy.44.4.271 12832592
11. Barone GW Gurley BJ Ketel BL Lightfoot ML Abul-Ezz SR Drug interaction between St. John's wort and cyclosporine Ann Pharmacother 2000, 34:1013-6. 10.1345/aph.10088 10981246
12. Marchetti S Mazzanti R Beijnen JH Schellens JHM Concise review: Clinical clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein) Oncologist 2007, 12(8):927-941. 10.1634/theoncologist.12-8-927 17766652
13. Piscitelli SC Burstein AH Chaitt D Alfaro RM Falloon J Indinavir concentrations and St John's wort Lancet 2000, 355:547-8. 10.1016/ S0140-6736(99)05712-8 10683007
14. Sarino LV Dang KH Dianat N Djihanian H Natanian N Hudmon KS Ambrose PJ Drug interaction between oral contraceptives and St. John's wort: appropriateness of advice received from community pharmacists and health food store clerks J Am Pharm Assoc (2003) 2007, 47(1):42-7. 10.1331/ 1544-3191.47.1.42.Sarino 17338474
15. Henderson L Yue QY Bergquist C Gerden B Arlett P St. John's wort (Hypericum perforatum): Drug interactions and clinical outcomes Br J Clin Pharmacol 2002, 54:349-56. 1874438 12392581 10.1046/ j.1365-2125.2002.01683.x
16. Moses EL Mallinger AG St. John's wort: Three cases of possible mania induction J Clin Psychopharmacol 2000, 20:115-17. 10.1097/ 00004714-200002000-00027 10653226
17. Hennessy M Kelleher D Spiers JP Barry M Kavanagh P Back D Mulcahy F Feely J St. John's wort increases expression of P-glycoprotein: implications for drug interaction Br J Clin Pharmacol 2002, 53:75-82. 1874544 11849198 10.1046/j.0306-5251.2001.01516.x
18. Moore LB Goodwin B Jones SA Wisely GB Serabjit-Singh CJ Willson TM Collins JL Kliewer SA St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor Proc Natl Acad Sci USA 2000, 97:7500-2. 16574 10852961 10.1073/pnas.130155097
19. Godtel-Armbrust U Metzger A Kroll U Kelber O Wojnowski L Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort Naunyn Schmiedebergs Arch Pharmacol 2007, 375:377-82. 10.1007/s00210-007-0172-8 17593354
20. Kwan D Hirschkorn K Boon H U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: A systematic review BMC Complement Altern Med 2006, 6:31. 1586212 16984649 10.1186/1472-6882-6-31
21. Kemper KJ Gardiner P Gobble J Woods C Expertise about herbs and dietary supplements among diverse health professionals BMC Complement Altern Med 2006, 6:15. 1557537 16646964 10.1186/1472-6882-6-15
22. Clement YN Williams AF Khan K Bernard T Bhola S Fortuné M Medupe O Nagee K Seaforth CE A gap between acceptance and knowledge of herbal remedies by physicians: The need for educational intervention BMC Complement Altern Med 2005, 5:20. 1310610 16297236 10.1186/1472-6882-5-20
23. Kemper KJ Amata-Kynvi A Dvorkin L Whelan JS Woolf A Samuels RC Hibberd P Herbs and other dietary supplements: Healthcare professionals' knowledge, attitudes, and practices Altern Ther Health Med 2003, 9:42-9. 12776474
24. Glisson JK Rogers HE Abourashed EA Ogletree R Hufford CD Khan I Clinic at the health food store? Employee recommendations and product analysis Pharmacotherapy 2003, 23:64-72. 10.1592/phco.23.1.64.31912 12523461
25. Mills E Singh R Kawasaki M Bast L Hart J Majlesi A Kiani P Wilson K Emerging issues associated with HIV patients seeking advice from health food stores Can J Public Health 2003, 94:363-6. 14577746
26. Wazaify M Shields E Hughes C McElmay J Societal perspectives on over-the-counter (OTC) medicines Fam Pract 2005, 22:170-6. 10.1093/ fampra/cmh723 15710640
27. Dailey DG Dresser GK Natural products and adverse drug interactions CMAJ 2004, 170:1531-32 400713 15136542
28. McGarry H Pirotta M Hegarty K Gunn J General practitioners and St. John's wort: A question of regulation or knowledge? Complement Ther Med 2007, 15:142-8. 10.1016/j.ctim.2006.02.002 17544866
29. Dietary Supplement Health and Education Act of 1994. Public Law 103-417, 103rd Congress http://www.fda.gov/opacom/laws/dshea.html (accessed February 17, 2008).
30. Boon HS Kachan N Natural health labels: Is more information always better? Patient Educ Couns 2007, 68:193-9. 10.1016/j.pec.2007.06.005 17693048
31. Miller CK Russell T Knowledge of dietary supplement label information among female supplement users Patient Educ Couns 2004, 52:291-6. 10.1016/ S0738-3991(03)00093-4 14998599
32. Gulick RM McAuliffe V Holden-Wiltse J Crumpacker C Liebes L Stein DS Meehan P Hussey S Forcht J Valentine FT Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258 Ann Intern Med 1999, 130:510-4. 10075619
33. Temple University. Novel Protein In St. John's Wort Found To Suppress HIV-1 Gene Expression. ScienceDaily 15 December 2007 http://www.sciencedaily.com/releases/2005/10/051025074707.htm (accessed February 17, 2008).
34. Darbinian-Sarkissian N Darbinyan A Otte J Radhakrishnan S Sawaya BE Arzumanyan A Chipitsyna G Popov Y Rappaport J Amini S Khalili K p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome Gene Ther 2006, 13:288-95. 10.1038/sj.gt.3302649 16251997
35. Clauson KA Santamarina ML Buettner CM Cauffield JS Evaluation of presence of aspirin-related warnings with willow bark Ann Pharmacother 2005, 39:1234-7. 10.1345/aph.1E650 15928264
36. Boullata JI McDonnell PJ Oliva CD Anaphylactic reaction to a dietary suppplement containing willow bark Ann Pharmacother 2003, 37:832-5. 10.1345/aph.1D027 12773073